JNJ-632

N/A

Report date: 2023/03/05 19:04:05
NME

Base Information

Drug NameJNJ-632
Drug Alias NameJNJ-632
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus inhibitors
TargetsHepatitis B virus
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A